Why the mycetoma patients are still neglected
Abstract
In 2012, pharmaceutical companies, donors, endemic countries, and nongovernment organisations met in London and signed the London Declaration on Neglected Tropical Diseases.Together, they committed to controlling, eliminating or eradicating ten diseases by 2020, and improving the lives of over a billion people.Great progress has been made, and the declaration has achieved many of its goals [1].Mycetoma was recognised as a neglected tropical disease (NTD) by the World Health Assembly in 2016 [2].GlobalAU : Pleasecheckandconfirmthattheedittothese measures have been initiated to assess the current policies and practices worldwide; international consultation to identify priority areas of work and a Global Mycetoma Working Group were established [3].The 17 Sustainable Development Goals (SDGs) of the 2030 Agenda for Sustainable Development were adopted by world leaders in 2015.They build on the success of the Millennium Development Goals and aim to go further to end all forms of poverty, calling for action by all countries to promote prosperity while protecting the planet.The third goal is the Good Health and Well-Being [3].The Sixth International Conference on Mycetoma and the First International Training Workshop on Mycetoma were organised in Khartoum, Sudan, by WHO and the Mycetoma Research Centre.The conference delegates have endorsed a "Call for action" urging the global community to work together with multilateral agencies, partners, research institutions, and pharmaceutical…
Read the paper
Related studies
- Challenges and opportunities with drug repurposing: finding strategies to find alternative uses of therapeutics
- Challenges in Chagas Disease Drug Development
- T Cell Specificity: A Great Challenge in Chagas Disease
- Benznidazole treatment leads to DNA damage in Trypanosoma cruzi and the persistence of rare widely dispersed non-replicative amastigotes in mice
- Rapid Molecular Detection of Terbinafine-resistant Dermatophytes
- Identifying novel drugs with new modes of action for neglected tropical fungal skin diseases (fungal skinNTDs) using an Open Source Drug discovery approach
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.